Latin America Point-of-Care Molecular Diagnostics Market (2025-2030)
The Latin America Point-of-Care Molecular Diagnostics Market was valued at $108.2 Million in 2025 and projected to reach to $171.7 Million by 2030, representing a compound annual growth rate of 9.7%. Latin America's point-of-care molecular diagnostics market is positioned for sustained growth through 2030, driven by increasing healthcare expenditure, rising infectious disease prevalence, and growing demand for rapid diagnostic solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Point-of-Care Molecular Diagnostics Market Trends and Insights
- This 9.7% compound annual growth rate reflects Latin America's increasing adoption of rapid diagnostic technologies across clinical and decentralized settings.
- Latin America is witnessing rising demand driven by improved healthcare infrastructure, growing prevalence of infectious diseases, and expanding access to point-of-care testing in remote and underserved regions. The market in Latin America is characterized by a shift toward faster, more accurate diagnostic solutions that reduce turnaround times and improve patient outcomes.
- Latin America's healthcare systems are increasingly investing in molecular diagnostics to enhance disease detection capabilities, particularly for respiratory infections, sexually transmitted infections, and other communicable diseases.
- Between 2025 and 2030, Latin America is expected to see accelerated adoption of portable and user-friendly molecular diagnostic platforms, supported by regulatory improvements and growing healthcare spending across the region..
Key Market Statistics
- CAGR (2025-2030) 9.7% CAGR
- Market Size, 2025 ~USD 108.2 Million
- Forecast, 2030 ~USD 171.7 Million
- Geography Latin America
Latin America Point-of-Care Molecular Diagnostics Market Overview
Strong Regional Growth Trajectory :
Latin America's point-of-care molecular diagnostics market is expanding at 9.7% CAGR, growing from USD 108.2 million in 2025 to USD 171.7 million by 2030, demonstrating robust regional adoption of rapid diagnostic technologies.
Brazil Leads Market Expansion :
Brazil represents the largest market in Latin America with USD 85.8 million in market size, driving innovation and adoption of molecular diagnostics across clinical laboratories and decentralized healthcare settings.
Rising Demand for Decentralized Diagnostics :
Latin American healthcare systems are increasingly adopting point-of-care molecular solutions to improve diagnostic accessibility in remote and underserved regions, addressing critical healthcare infrastructure gaps.
Improved Healthcare Infrastructure Investment :
Growing government and private sector investments in healthcare modernization across Latin America are accelerating the deployment of rapid molecular diagnostic technologies in clinical and community settings.
Latin America Point-of-Care Molecular Diagnostics Market Dynamics
- The region's healthcare systems are prioritizing decentralized testing capabilities to improve patient outcomes and reduce diagnostic turnaround times, particularly in underserved populations. Key growth drivers include expanding healthcare infrastructure investments, rising awareness of molecular diagnostics benefits, and supportive regulatory environments in major markets like Brazil and Mexico.
- Strategic partnerships between diagnostic manufacturers and regional healthcare providers are expected to accelerate market penetration, while technological advancements in portable and user-friendly molecular platforms will further enhance adoption across clinical and point-of-care settings..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Latin America's point-of-care molecular diagnostics market is valued at USD 108.2 million in 2025 and will grow to USD 171.7 million by 2030, representing a 9.7% CAGR.
- Latin America is experiencing increased demand for rapid diagnostic solutions driven by rising infectious disease prevalence and improved healthcare infrastructure investment.
- Latin America's market growth is supported by expanding access to point-of-care testing in remote and underserved regions across the continent.
- Latin America's healthcare systems are prioritizing portable and user-friendly molecular diagnostic platforms to enhance disease detection and reduce diagnostic turnaround times.
Point-of-Care Molecular Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SEPSIS (Disease Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 10.5% from 2025 to 2030 |
| Largest Segment | RT-PCR (Technology) |
| Market Size Base Year (Billions) | ~USD 4.3 (2025) |
| Revenue Forecast (Billions) | ~USD 7.09 (2030) |
| Segments Covered | Product & Service, Technology, Sample Type, Application, End User, Disease Type |
Latin America Point-of-Care Molecular Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Assays & Kits
- Instruments & Analyzers
- Software & Services
By Technology
- Inaat
- Other Technologies
- Rt-Pcr
By Sample Type
- Blood Samples
- Other Sample Types
- Urine Samples
By Application
- Cancer
- Gastrointestinal Disorders
- Hepatitis
- Hospital-Acquired Infections
- Other Applications
- Respiratory Diseases
- Sexually Transmitted Diseases
By End User
- Hospitals
- Other End Users
- Physicians' Offices/Clinics
- Research Institutes
By Disease Type
- Gastroenteritis
- Meningoencephalitis
- Other Diseases
- Sepsis
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need Latin America market data to identify expansion opportunities, assess market potential in Brazil and Mexico, and develop region-specific product strategies for point-of-care molecular platforms.
- Healthcare System Administrators : Hospital networks and healthcare providers require market intelligence to justify investments in point-of-care molecular diagnostics infrastructure and optimize diagnostic service delivery across Latin American facilities.
- Investment & Private Equity Firms : Investors evaluating Latin America healthcare opportunities need comprehensive market sizing and growth forecasts to assess portfolio companies, identify acquisition targets, and evaluate regional market potential.
- Regulatory & Policy Makers : Government health agencies and regulatory bodies use market data to inform healthcare policy decisions, allocate resources for diagnostic infrastructure, and support evidence-based healthcare modernization initiatives.
- Market Research & Consulting Professionals : Consultants and analysts require detailed Latin America market segmentation and forecasts to support client advisory services, competitive analysis, and strategic planning recommendations in the diagnostics sector.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 85.8 Million |
| Mexico | USD 43.1 Million |
| Rest Of Latin America | USD 42.7 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Projections : Access precise market valuations for Latin America (USD 108.2M in 2025, USD 171.7M in 2030) with detailed 9.7% CAGR analysis to support investment decisions and business planning in the region.
- Country-Level Market Intelligence : Gain granular insights into Brazil (USD 85.8M) and Mexico (USD 43.1M) market dynamics, enabling targeted market entry strategies and competitive positioning within Latin America's largest diagnostic markets.
- Regional Adoption Trends & Drivers : Understand Latin America-specific factors driving point-of-care molecular diagnostics adoption, including healthcare infrastructure improvements, disease prevalence patterns, and decentralized testing demand.
- Competitive Landscape Analysis : Benchmark your organization against regional competitors and identify market opportunities in Latin America's rapidly expanding point-of-care molecular diagnostics segment with actionable competitive insights.
- Strategic Market Expansion Planning : Develop data-driven expansion strategies for Latin America with comprehensive market forecasts, regulatory insights, and growth opportunity identification through 2030.
Frequently asked questions
What is the current market size of point-of-care molecular diagnostics in Latin America?
Latin America's point-of-care molecular diagnostics market is valued at USD 108.2 million in 2025.
What is the projected market size for Latin America by 2030?
Latin America's point-of-care molecular diagnostics market is projected to reach USD 171.7 million by 2030.
What is the growth rate for point-of-care molecular diagnostics in Latin America?
Latin America's point-of-care molecular diagnostics market is expected to grow at a compound annual growth rate of 9.7% from 2025 to 2030.
What factors are driving growth in Latin America's point-of-care molecular diagnostics market?
Latin America's market growth is driven by improved healthcare infrastructure, rising infectious disease prevalence, expanding access to testing in remote regions, and increased healthcare spending.
Which diseases are most commonly diagnosed using point-of-care molecular tests in Latin America?
In Latin America, point-of-care molecular diagnostics are primarily used for respiratory infections, sexually transmitted infections, and other communicable diseases.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the point-of-care molecular diagnostics market. Exhaustive secondary research was done to collect information on the point-of-care molecular diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the point-of-care molecular diagnostics market.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold-standard & silver-standard websites; regulatory bodies; and databases like D&B Hoovers, Bloomberg Business, and Factiva, were referred to identify and collect information for this study.
Primary Research
In the primary research process, primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
Breakdown of Primaries
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both bottom-up and top-down approaches were used to estimate and validate the point-of-care molecular diagnostics market’s total size. These methods were also used extensively to estimate the size of various subsegments in tkehe mart. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenues generated by leading players operating in the point-of-care molecular diagnostics market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Point-of-care molecular diagnostics includes various portable point-of-care devices and assays used by healthcare professionals to detect and diagnose diseases in humans using different techniques to identify and analyze nucleic acids or proteins at the molecular level.
Stakeholders
- Manufacturers and distributors of point-of-care molecular diagnostics products
- Physicians’ offices
- Hospitals and clinics
- Research institutes
- Point-of-care molecular diagnostics service providers
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, segment, and forecast the point-of-care molecular diagnostics market by product & service, technology, sample type, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as acquisitions, expansions, product launches & approvals, and other developments in the point-of-care molecular diagnostics market
- To benchmark players within the point-of-care molecular diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full Point-of-Care Molecular Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Point-of-Care Molecular Diagnostics Market.
- US Point-of-Care Molecular Diagnostics Market
- Canada Point-of-Care Molecular Diagnostics Market
- Germany Point-of-Care Molecular Diagnostics Market
- UK Point-of-Care Molecular Diagnostics Market
- France Point-of-Care Molecular Diagnostics Market
- Italy Point-of-Care Molecular Diagnostics Market
- Spain Point-of-Care Molecular Diagnostics Market
- China Point-of-Care Molecular Diagnostics Market
- Japan Point-of-Care Molecular Diagnostics Market
- India Point-of-Care Molecular Diagnostics Market
- Brazil Point-of-Care Molecular Diagnostics Market
- Mexico Point-of-Care Molecular Diagnostics Market
- Rest Of Europe Point-of-Care Molecular Diagnostics Market
- Rest Of Asia Pacific Point-of-Care Molecular Diagnostics Market
- Rest Of Latin America Point-of-Care Molecular Diagnostics Market
- Ksa Point-of-Care Molecular Diagnostics Market
- UAE Point-of-Care Molecular Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
